Fig. 5From: Tumor mutation burden-related long non-coding RNAs is predictor for prognosis and immune response in pancreatic cancerAssociation of the 14-lncRNAs prognostic model and clinicopathological features. (A) Comparison of clinical features between high-risk and low-risk groups in the TCGA-PAAD cohort. (B) Comparison of tumor mutation burden (TMB) between high-risk and low-risk groups in the TCGA-PAAD cohort. (C) Comparison of microsatellite instability (MSI) between high-risk and low-risk groups in the TCGA-PAAD cohort. (D) Comparison of fraction genome altered (FGA) between high-risk and low-risk groups in the TCGA-PAAD cohort. (E) Comparison of homologous recombination deficiency (HRD)-score between high-risk and low-risk groups in the TCGA-PAAD cohort. “*” represents p < 0.05, “***” represents p < 0.001, “****” represents p < 0.0001Back to article page